An artificial intelligence tool called DystoniaBoTXNet predicted which patients with dystonia would benefit from botulinum toxin injections with 96.3% accuracy. DystoniaBoTXNet could be a tool to aid clinical decision-making and address some of the issues patients with dystonia face with overtreatment and undertreatment with this first-line therapy.
Click here for original story, Artificial intelligence tool predicts which patients with dystonia respond to Botox treatment with 96 percent accuracy
Source: ScienceDaily